COPPELL, Texas--(BUSINESS WIRE)--Jun. 25, 2012--
Mannatech,
Incorporated (NASDAQ: MTEX),
the leading innovator and provider of naturally sourced supplements
based on Real
Food Technology® solutions, recently presented
product research at the 9th Annual International Society of
Sports Nutrition Conference and Expo, which was held in Clearwater,
Fla., on June 22-23, 2012.
The open-label human clinical trial showed that intake of Mannatech
products resulted in statistically significant improvements in numerous
self-reported measures of physical and mental health, quality of life,
memory, and elbow and knee pain reduction.*† The 15 retired
football players who participated in the study took Mannatech’s Ambrotose®
complex powder, Omega-3 with Vitamin D3, Ambrotose AO®
capsules, PhytoMatrix® caplets and PLUS™ caplets.
The study was authored by Dr. Robert Sinnott, Dr. Rolando L. Maddela,
Dr. Sejong Bae and Dr. Talitha Best. Dr. Sinnott is the CEO and Chief
Science Officer at Mannatech, and Dr. Maddela is the Clinical Research
Administration Manager at Mannatech. Dr. Bae is a Professor in the
Department of Biostatistics at the University of North Texas Health
Science Center’s School of Public Health in Fort Worth, Texas; Dr. Best
is a Research Fellow in the Nutritional Physiology Research Center,
Sansom Institute for Health Research, University of South Australia,
Adelaide, South Australia.
The International Society of Sports Nutrition’s annual conference and
expo brings together scientists, physicians and athletes interested in
sharing the latest science evaluating nutritional and behavioral
approaches to optimizing human health and performance. More information
about the meeting can be found here: https://www.sportsnutritionsociety.org/CONBrochures/issn9thannualco.pdf
*This statement has not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.
†This study was funded by Mannatech.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales Associates around the globe including the United
States, Canada, South Africa, Australia, New Zealand, Austria, Denmark,
Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan,
Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech
Republic, the Republic of Korea, Mexico and Namibia. For more
information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “believe,” “intend” or other similar words or the
negative of such terminology. Similarly, descriptions of Mannatech’s
objectives, strategies, plans, goals or targets contained herein are
also considered forward-looking statements. Mannatech believes this
release should be read in conjunction with all of its filings with the
United States Securities and Exchange Commission and cautions its
readers that these forward-looking statements are subject to certain
events, risks, uncertainties and other factors. Some of these factors
include, among others, Mannatech’s inability to attract and retain
Associates and Members, increases in competition, litigation, regulatory
changes and its planned growth into new international markets. Although
Mannatech believes that the expectations, statements and assumptions
reflected in these forward-looking statements are reasonable, it
cautions readers to always consider all of the risk factors and any
other cautionary statements carefully in evaluating each forward-looking
statement in this release, as well as those set forth in its latest
Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other
filings filed with the United States Securities and Exchange Commission,
including its current reports on Form 8-K. All of the forward-looking
statements contained herein speak only as of the date of this release.
Source: Mannatech, Incorporated
Mannatech, Incorporated
Brett Duncan, 972-471-7367
bduncan@mannatech.com